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Undocumented migrant women in
Denmark have inadequate access to
pregnancy screening and have a higher
prevalence Hepatitis B virus infection
compared to documented migrants in
Denmark: a prevalence study
Annika Wendland1,2*, Boje K. Ehmsen3, Vibeke Lenskjold4, Birgitte S. Astrup5, Marlene Mohr6,
Christopher J. Williams2,7 and Susan A. Cowan1
Abstract
Background: Pregnant residents of Denmark are tested by their GP for current infections with Hepatitis B virus
(HBV), HIV and syphilis through the Danish pregnancy screening programme to identify infections and initiate
interventions to prevent mother-to-child transmission. Documented migrants (DM) have access to this screening
but undocumented migrants (UM) do not, instead relying on ad-hoc care from clinics run by non-governmental
organisations. We aimed to assess screening frequency in UM and to compare prevalence of infection in UM with DM.
Methods: We obtained individual-level information on HBV, HIV and syphilis testing frequency and results for pregnant
women attending three clinics specialising in care for UM between August 2011 and August 2014. We obtained
aggregate data on the prevalence of the three infections for documented migrants from the Danish pregnancy
screening programme and birth register between January 2011 and January 2014. Planned abortions were excluded from
the study. We described demographic features of pregnant UM and estimated the screening frequency for HIV, HBV and
syphilis. We compared prevalence of current infections in UM and DM by calculating standardised prevalence ratios (SPR).
Results: The three UM clinics registered 219 pregnancies qualifying for screening. Overall 43, 58 and 60 % of pregnant
UM had a test result recorded for HBV, Syphilis and HIV respectively, compared to >99 % in the general Danish
population including DM.
The prevalence of HBV was higher in UM than in DM (SPR: 2.4; 95 % CI: 1.1–5.3). The SPR of 2 (95 % CI: 0.5–8.0) for HIV
was not statistically significant, potentially due to small sample size of UM. None of the pregnant UM tested positive for
Syphilis.
Conclusions: Pregnant UM have a poorer chance of being tested for HIV, HBV and syphilis, despite having a higher
prevalence of HBV than DM. We recommend giving systematic access to routine pregnancy screening to all UM to
prevent mother-to-child transmission and to address the observed health care inequity.
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Background
Undocumented migrants (UM) are persons living in a
country different to their country of origin with no offi-
cial registration in their country of residence. The major-
ity of member states of the United Nations have ratified
treaties recognizing the right to equal and equitable ac-
cess to health care for all persons, notwithstanding their
legal standing within a government system [1]. Access to
health care for UM however varies considerably between
countries, and is generally lower than for legal residents
[1–3]. Not having access to appropriate care can lead to
severe outcomes of infections that could otherwise be
managed or treated.
Screening of pregnant women for HIV, Hepatitis B
(HBV) and syphilis is an effective method to detect infec-
tion in the mother. Simple and cost effective interventions
are available to prevent mother-to-child transmission of
these illnesses. If untreated, the risk of mother-to-child
transmission of HIV during pregnancy, delivery or breast-
feeding is 20–25 % and administration of antiretroviral
drugs can reduce this risk to <1 % [4]. HBV infection of
babies is associated with prematurity and lower birth-
weight, and 90 % of newborns infected with HBV develop
chronic hepatitis if no vaccination is administered at birth
[5]. Treatment with penicillin before the 12th week of
pregnancy reduces the likelihood of complications due to
syphilis from 20 to 70 to 2 % [6].
Denmark signed the UN treaties assuring equal and
equitable access to health care. The Danish population
of UM has increased from between 9000 and 21,000 per-
sons in 2008 to 20,000–49,000 people in 2013 [7]. UM
do not have the right to apply for a civil registration
number (CPR number) entitling them to free access to
health care services in Denmark. Their contacts with
healthcare, including administered treatments, are not
recorded in official databases.
The Danish pregnancy screening programme includes
testing of all expecting mothers for HIV, HBV and syph-
ilis. The implementation of universal pregnancy screen-
ing in Denmark was a consequence of inconsistent
testing when targeting ‘at risk’ populations only. As a re-
sult, children were born without receiving appropriate
interventions, resulting in mother-to-child transmission
of preventable infectious diseases [8]. In 2013, between
99 and 100 % of the pregnant population were screened
for those three pathogens and 0.26 % tested positive for
HBV, 0.06 % tested positive for HIV and 0.005 % tested
positive for syphilis. The majority of those infections
were in documented migrants (DM) and were acquired
outside of Denmark [9].
UM do not have access to the Danish pregnancy
screening programme and instead rely on ad-hoc care
from clinics run by non-governmental organisations
(NGO clinics) specialising in UM health. In one of these
clinics located in Copenhagen, a high proportion (12.9 %)
of visits were related to pregnancy, childbearing and fam-
ily planning [10]. We aimed to: 1) describe UM attending
the clinics for a pregnancy, including gestational age at
first visit, country of origin and pregnancy outcome; 2) es-
timate the proportion of pregnant UM attending NGO
clinics, by region of origin, that are screened for HIV,
HBV and syphilis; 3) estimate the number of pregnant
UM and DM in Denmark testing positive for HIV, HBV
and syphilis and compare the prevalences between the
two groups, stratified by region of origin; and 4) identify if
pregnant UM who tested positive for HIV, HBV and/or
syphilis were followed up adequately to prevent mother-
to-child transmission. Based on the study results we aimed
to make recommendations to optimise screening and
treatment of pregnant UM and their children, to prevent
mother-to-child transmission of HIV, HBV and syphilis.
Methods
Sampling
We retrospectively identified pregnant UM residing in
Denmark through three NGO clinics specializing in pro-
viding care to UM. All three clinics referred persons
with CPR numbers to the Danish health care system,
and therefore only registered UM in their own data-
bases. We obtained information on females aged be-
tween 18 and 45 years at the time of data collection,
who had visited the clinics between August 2011 and
August 2014. Clinic A is located in Copenhagen and is
open to all undocumented migrants. Note that for clinic
A, we only extracted information until the end of May
2014. Clinic B is located in Jutland, the western part of
Denmark and focuses on trafficked individuals, primarily
sex workers. Clinic C is located in Copenhagen and has
the same target population as clinic B.
Individual level information on DM was not available
for the study. To estimate the proportion of pregnant
DM screening positive, we obtained denominator data
from the Danish Statistics Department on the number of
children born in Denmark between 2011 and 2013,
stratified by country of origin of the mother. Following a
previously used approach [8], we considered the number
of children born as a proxy for the number of pregnant
women in Denmark with non-Danish origin. For the nu-
merators, we obtained screening results for women from
the Danish pregnancy screening database, housed at the
Statens Serum Institut, which records all positive test re-
sults for HIV, HBV and syphilis. Only women who choose
to keep their pregnancy are screened in the Danish preg-
nancy screening programme.
Data collection
For UM, we extracted information on pregnancy status
(pregnancy with no adverse outcome recorded, planned
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abortion, spontaneous abortion, post-natal visit), date of
birth, date of first pregnancy related visit, country of ori-
gin, gestational week at first pregnancy visit, whether a
specimen was collected for HIV, HBV and syphilis
screening, and any test results recorded for those three
illnesses. Additionally, we collected information on fol-
low up done for women who had a positive test result
recorded. Data was obtained from electronic patient
management software, electronic and paper based preg-
nancy journals, electronic and paper based laboratory
results and additional paper based patient records, as
available in the clinics.
For DM, we extracted all births from 2011 to 2013
(3 years) by year of birth and mother’s country of origin
from the Danish Statistics Department website. Add-
itionally, we extracted all positive HIV, HBV and syphilis
test results by country of origin of the mother from the
Danish pregnancy screening database.
Laboratory testing
We considered a positive screening result recorded in
any of the data sources as a positive case. The tests used
in the different clinics are listed in Table 1.
Exclusions
In the Danish pregnancy screening programme, women
who wish to have an abortion are not offered routine
pregnancy screening. We therefore excluded UM with a
recorded planned abortion from the study population.
Proportion of women screened
We defined a pregnancy as successfully screened if a
negative or positive test result was recorded during the
pregnancy with no subsequent note of test failure. We
made note of specimens collected with no result re-
corded, but did not include these episodes in further
analysis. For episodes with a specific reason given for
not testing, we recorded the reason and classified the
patient as not tested. Finally, if the notes (including all
laboratory and patient records) contained no record of
either testing or not testing, we considered the patient
not screened for the purpose of this paper. To calculate
screening frequency, we divided the number of women
with a screening result recorded by the total number of
women eligible for screening.
Measuring prevalence of key infections
For UM, we calculated the prevalence for each illness by
dividing the number of positive tests by the number of
episodes with a screening result recorded (positive of
negative), stratified by region of origin.
For DM, we divided the total number of pregnant
women testing positive for HIV, HBV and syphilis
through the Danish pregnancy screening programme, by
the number of children born to women with non-Danish
origin, stratified by region of origin.
Follow up of UM women testing positive
We read medical records (paper based and electronic) of
women with positive test results, and spoke to clinic
staff to ascertain which follow up was done.
Statistical analysis
We calculated median gestational age at first visit in-
cluding the interquartile range (non-normal distribution
of gestational age).
To estimate the standardised prevalence ratio (SPR) of
UM vs DM for each infection, we first calculated the ex-
pected number of positive cases for our UM sample size,
based on the observed prevalences in DM, by region of
origin. We then added the number of expected positives
from the different regions, to obtain the overall number
of expected cases. Subsequently we compared the observed
with the expected number of positives in UM and esti-
mated the SPR and 95 % confidence intervals.
Table 1 Tests used for diagnosis of HIV, HBV and syphilis at the participating clinics and in the Danish pregnancy screening programme
Facility HIV test used HBV test used Syphilis test used
Clinic A Visual read qualitative immunoassay
(Alere™ Determine™ HIV-1/2, Alere
Medical Co. Ltd., Japan)
Hepatitis B surface antigen test (LIAISON®
XL, DiaSorin S.p.A, Saluggia, Italy)
Point of care test (Core™ Syphilis, CORE Diagnostics,
England), and confirmatory test in microbiological
laboratory
Clinic B HIV antibody test (ADVIA Centaur
CP Immunoassay System, Siemens
Healthcare GmbH, Germany)
Hepatitis B surface antigen test (ADVIA
Centaur CP Immunoassay System,
Siemens Healthcare GmbH, Germany)
Treponema antibody screening and Trepanmoa
pallidum confirmatory test (ADVIA Centaur CP
Immunoassay System, Siemens Healthcare GmbH,
Germany)
Clinic C Visual read qualitative immunoassay
(Alere™ Determine™ HIV-1/2, Alere
Medical Co. Ltd., Japan)
Hepatitis B surface antigen test (ADVIA
Centaur XP Immunoassay System,
Siemens Healthcare GmbH, Germany)
Point of care test (Core™ Syphilis, CORE Diagnostics,
England), England and confirmatory test in
microbiological laboratory
Danish
pregnancy
screening
program
Tested at Danish blood banks, using a variety of automated diagnostic platforms
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We used Stata statistical software, version 12.1 (Stata-
Corp LP, 4905 Lakeway Drive, College Station, TX
77845, USA) and Statistical Analysis System (SAS) soft-
ware, version 9.4 (SAS Institute Inc, 100 SAS Campus
Drive, NC 27513–2414, USA).
Results
Description of population
Between January 2011 and May 2014, UM visited the
three clinics for 329 pregnancy related episodes. Of
those, 201 (61 %) were for pregnancies with no recorded
complications and 18 (5 %) resulted in spontaneous
abortions. Planned abortions were performed for 77
(23 %) of the episodes, and 33 (10 %) related to post-
natal visits (Fig. 1, Table 2). We considered episodes
qualifying for screening if women were pregnant at the
time of the visit and no planned abortion was recorded
in the notes.
Gestational age at first visit was available for clinic A
and B. Excluding visits related to planned abortions, the
median gestational age at first visit was 12 weeks (IQR: 8
to 21 weeks). Women presented for the first time as late
as week 41 of their pregnancy. Of 183 pregnancy related
visits, 97 (53 %) occurred after week 10 of pregnancy.
Planned abortions were more common at sex worker
clinics (B and C) than general UM clinic (A) (50–71 %
vs 15 % of episodes). Sex worker clinic B had the highest
proportion of Eastern European women (45 %), sex
worker clinic C the highest proportion of Sub-Saharan
African women (58 %), whereas general UM clinic A
had a more even distribution of countries of origin with
the most represented group coming from Sub-Saharan
Africa (27 %) (Table 2).
Pregnant women positive for
HIV: n=2
HBV: n=6
Syphilis: n=0
Pregnant women negative for:
HIV: n=130
HBV: n=88
Syphilis: n=127
Pregnancy related episodes
n=329
Excluded planned abortions and 
postnatal visits, as these would 
not qualify for routine pregnancy 
screening
Episodes qualifying for screening
n=219
Where no record of testing was 
available in either electronic 
databases or paper based 
records (laboratory and 
medical), the woman was 
considered ‘not tested’
Excluded women for whom only 
a specimen was taken but no 
valid result was recorded
Pregnant women for whom a 
specimen was taken
HIV: n=134
HBV: n=105
Syphilis: n=127
Pregnant women for whom a test 
result was reported (% of qualifying 
for screening)
HIV: n=132 (60%)
HBV: n=94 (43%)
Syphilis: n=127 (58%)
Fig. 1 Selection of pregnant undocumented migrant women at 3 NGO clinics, for the study of screening patterns and prevalence of HIV, HBV
and Syphilis, Denmark, August 2011 to August 2014
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Proportion of women screened
Overall, 219 episodes qualified for screening (Fig. 1).
For HIV, 134 specimens were taken and 132 (60 %)
had a screening result recorded (Fig. 1). Screening com-
pleteness ranged from 51 to 73 %. It was highest in
women from the Middle East and North African coun-
tries and lowest in women from the Indian subcontinent
and of Sub-Saharan origin (Table 3).
For HBV, 105 specimens were collected and screening
results were available for 94 (43 %) of them (Fig. 1).
Screening completeness ranged from 27 to 55 % (exclud-
ing “Other”) and was highest in South- and Middle
American women, and lowest in women from the Indian
subcontinent (Table 3).
Syphilis specimens were taken for 127 episodes (58 %)
and all had a screening result recorded (Fig. 1). Between
49 and 70 % of women were screened, with complete-
ness highest in women from Middle Eastern and North
African (MENA) countries and lowest in women from
the Indian subcontinent (Table 3).
Reasons for not screening
According to the medical records sighted (only available
for clinic A and B), 47 of 78 women who were not
screened had no reason recorded. Of those with a reason
recorded, 11 were lost to follow up, nine had left the
country, and seven were referred to a specialist clinic.
The remaining four were not tested because they either
declined the test, the test was unavailable at the time of
visit, the consultation was unrelated to pregnancy or a
previous positive test was done elsewhere prior to visit.
Table 2 Pregnancy status and country of origin for undocumented migrants presenting to three NGO health clinics in Denmark,
August 2011 to August 2014
Clinic A Clinic B Clinic C Total
Number % Number % Number % Number %
Total 267 38 24 329
Pregnancy status Normal pregnancy 181 68 % 14 37 % 6 25 % 201 61 %
Spontaneous abortion 15 6 % 2 5 % 1 4 % 18 5 %
Planned abortion 41 15 % 19 50 % 17 71 % 77 23 %
Postnatal visit 30 11 % 3 8 % 0 0 % 33 10 %
Region of origin Eastern Europe 41 15 % 17 45 % 5 21 % 63 19 %
Indian subcontinent 43 16 % 0 0 % 0 0 % 43 13 %
Middle East/ North Africa 45 17 % 3 8 % 0 0 % 48 15 %
North America 1 0 % 0 0 % 0 0 % 1 0 %
South- and Middle America 12 4 % 6 16 % 0 0 % 18 5 %
South-East Asia 50 19 % 1 3 % 2 8 % 53 16 %
Sub-Saharan Africa 73 27 % 11 29 % 14 58 % 98 30 %
Western Europe 1 0 % 0 0 % 0 0 % 1 0 %
unknown 1 0 % 0 0 % 3 13 % 4 1 %
Table 3 Number and proportion of pregnant undocumented migrants (UM) out of total number of episodes eligible for screening,
presenting to three NGO health clinics in Denmark, August 2011 to August 2014
Pregnant UM qualifying for screening UM seen at 3 clinics, for whom test result was recorded
HIV HBV Syphilis
Subregion of origin Number Number % Number % Number %
Eastern Europe 35 20 57 % 16 46 % 18 51 %
Indian subcontinent 37 19 51 % 10 27 % 18 49 %
Middle East/ North Africa 37 27 73 % 20 54 % 26 70 %
South- and Middle America 11 7 64 % 6 55 % 7 64 %
South-East Asia 36 25 69 % 18 50 % 25 69 %
Sub-Saharan Africa 60 32 53 % 22 37 % 31 52 %
Other 3 2 67 % 2 67 % 2 67 %
Total 219 132 60 % 94 43 % 127 58 %
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Prevalence of HIV, HBV and syphilis
Of the 132 specimens with a screening result for HIV,
two tested positive. Both cases attended clinic A. Ex-
trapolating from the prevalence observed in DM, we
would have expected to identify one positive case of
HIV for our sample size. The standardized prevalence
ratio (SPR) indicated double the prevalence of HIV in
UM compared to DM, but the difference was statistically
not significant. For HBV, six of 92 specimens tested
positive, compared to an expected 2.51 cases testing
positive. The SPR of 2.4 (95 % CI 1.1–5.3) indicates a
significantly higher prevalence of HBV in UM compared
to DM. Five of the specimens tested positive at clinic A
and the sixth specimen originated from clinic B. None of
the pregnant UM tested positive for syphilis (Table 4).
Follow up of UM women testing positive
At one clinic, two of the women with positive tests for
HBV were initially falsely classified as negative, and fol-
low up had not been initiated until we conducted this
study. One woman could be contacted. She had obtained
a Danish residency permit and we referred her to her
general practitioner for appropriate follow up of her and
her child. The other woman was lost to follow up and
no information was available on whether vaccinations
were administered to her child.
Of the 4 pregnancies correctly diagnosed as HBV posi-
tive, one attended the clinic only once and returned to her
home country. Information was provided to her over the
phone regarding her test result and the consequences, and
she was advised to enrol in the pregnancy care programme
of her home country. One woman had full records of fol-
low up and vaccination of the child at the NGO clinic.
One woman had a spontaneous abortion at 3 months and
the fourth woman had no follow up recorded in the notes.
The women testing positive for HIV were both referred
to venereal departments in Danish hospitals for follow up.
Discussion
Late presentation
Just over half of the women visited the clinic for the first
time after week 10 of their pregnancy. The recommendation
Table 4 Comparison of HIV, HBV and syphilis in documented vs undocumented migrants presenting to three NGO health clinics in
Denmark, August 2011 to August 2014
Documented migrants (DM)a Undocumented migrants (UM) UM vs DM
Total
Population
Observed
cases
Cases per
1000
Sampled
Population
Observed
cases
Expected
cases
Cases per
1000
SPRb 95 % CI
HIV Eastern Europe 7202 11 1.5 20 0 0.03 -
Indian subcontinent 1864 1 0.5 19 0 0.01 -
Middle East/ North Africa 6390 1 0.2 27 0 0.00 -
South- and Middle America 759 3 4.0 7 0 0.03 -
South-East Asia 3066 8 2.6 25 0 0.07 -
Sub-Saharan Africa 2379 64 26.9 32 2 0.86 62.5
Total 21,660 88 4.1 130 2 1.00 15.4 2.0 0.5–8.0
HBV Eastern Europe 7202 82 11.4 16 1 0.18 62.5
Indian subcontinent 1864 16 8.6 10 0 0.09 -
Middle East/ North Africa 6390 79 12.4 20 1 0.25 50.0
South- and Middle America 759 3 4.0 6 0 0.02 -
South-East Asia 3066 192 62.6 18 0 1.13 -
Sub-Saharan Africa 2379 91 38.3 22 4 0.84 181.8
Total 21,660 463 21.4 92 6 2.51 65.2 2.4 1.1–5.3
Syphilis Eastern Europe 7202 51 7.1 18 0 0.13 -
Indian subcontinent 1864 2 1.1 18 0 0.02 -
Middle East/ North Africa 6390 16 2.5 26 0 0.07 -
South- and Middle America 759 12 15.8 7 0 0.11 -
South-East Asia 3066 24 7.8 25 0 0.20 -
Sub-Saharan Africa 2379 38 16.0 31 0 0.50 -
Total 21,660 143 6.6 125 0 1.01 - - -
adocumented migrants were considered the standard population composition for migrants in Denmark and used to calculate the expected number of
undocumented migrant cases
bSPR standardised prevalence ratio
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for the first pregnancy related visit in Denmark is between
gestational week 6 and 10. Late presentation for pregnancy
related care may lead to delayed interventions for the
prevention of mother-to-child transmission of infec-
tious diseases. Possible barriers to accessing health
services include limited medical rights, fear of being
reported to the police, poor language skills and lack of
knowledge about the healthcare system and informal
networks of healthcare professionals [11].
Abortions
A large proportion (50–71 %) of women attending the
two sex worker clinics requested an abortion, suggesting
a high level of unplanned pregnancies. Two studies from
Switzerland showed that UM in general reported a high
proportion of unplanned pregnancies (75 to 83 %) [12, 13]
but we are unable to identify how many pregnancies be-
yond those resulting in an abortion were unplanned in
our study. The information collected in this study did not
allow distinguishing if women attending sex worker clinics
fell pregnant to their regular partners or clients. Sex
workers may use condoms consistently with their clients
but may have unprotected sex with their partners, as a
symbol of a more intimate relationship [14–16]. The high
level of planned abortions indicates a need for better ac-
cess to contraceptives and potentially a need for family
planning services for UM, particularly for women working
in the sex industry.
Screening and prevalence
HIV
Only 60 % of women eligible for screening had a HIV
test result recorded, compared to 99.9 % of the Danish
population with legal residency status [9]. Screening was
amongst the lowest in women of Sub-Saharan African
origin, a concerning result, as prevalence of HIV is ex-
pected to be highest in that population. The observed num-
ber of cases in the UM population was two times higher
than for DM, and the two cases detected were in Sub-
Saharan African women attending clinic A, which is not a
specialised sex worker clinic. The result was not statistically
significant and the power of the study was too small to
observe significant differences between UM and DM.
Early detection and treatment of pregnant women infected
with HIV increases the chances of favourable outcomes for
the child. Controlling the viral load will reduce the risk of
intrauterine and post-natal transmission of HIV to the child.
Late presentation during pregnancy may not allow for the
reduction of the viral load to satisfactory level in time for the
birth and increases the risk of infection in the child [4].
HBV
We observed the lowest percentage of recorded screen-
ing results for HBV: overall, only 43 % of pregnant UM
had a screening result recorded, compared to 99.9 % of
pregnant women with legal residency in Denmark [9].
Screening for HBV required sending of specimens to the
laboratory, as there is currently no point of care test ap-
proved in Denmark. It is therefore a less convenient test
to conduct and increases chances of either not testing or
not documenting a test result in the patient’s records.
Our study results showed a 2.4 times higher prevalence
of women testing positive for HBV during pregnancy if
they are UM compared to DM.
A study published in 2015 found that 6 % of
migrants – 94.2 % of which were undocumented -
screened for HBV were found to be HBV surface
antigen positive [17]. This is comparable to our find-
ings, where we found a HBV prevalence of 6.1 % in
our UM population.
WHO has classified the regions in the world by low,
intermediate and high endemicity of HBV. Sub-Saharan
African and South-East Asian countries fall into the
high-endemicity areas, with prevalence of HBV >8 %.
Eastern Europe, the Indian subcontinent, some South-
and Middle American and MENA countries are classified
as intermediate endemicity with prevalences of 2–7 %
[18]. In these populations, screening would be particularly
important, but in our study, only 37–50 % of women from
high prevalence regions and 27–55 % of women from
intermediate prevalence regions had a record of screening.
Given the potential high prevalence of HBV in UM com-
ing from these regions, low screening levels create a real
risk that babies are born to undiagnosed HBV positive
mothers, potentially missing the opportunity of vaccin-
ation to prevent HBV infection.
Women positive for HBV with high viral loads are
more likely to transmit HBV to their children, even if
the children receive the recommended vaccination course
from birth. Detection of the illness during pregnancy al-
lows for the administration of antivirals, reducing the risk
of infection in the child which often leads to the develop-
ment of a chronic HBV infection [19].
Syphilis
For syphilis, 58 % of UM women had a recorded screen-
ing result, compared to 99.7 % in pregnant women with
documented residence in Denmark. We expected to de-
tect approximately one case of syphilis given the popula-
tion size and region of origin, but none of the women
tested positive. Given the rarity of syphilis infection, the
power of this study is likely too small to detect any
significant differences in syphilis prevalence between
UM and DM.
A concerning aspect for the management of syphilis in
pregnant women is the relatively late presentation for
first pregnancy related health checks, with 42 % of UM
in this study attending a clinic after week 12 of their
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pregnancy. For syphilis, antibiotic treatment should be
initiated by week 12 of pregnancy to prevent complications
including spontaneous abortions, premature delivery, still-
births, perinatal death or serious sequelae in children born
with congenital syphilis [6].
Follow up
Two women who tested positive for HBV by HBsAg test
were falsely noted as negative in the patient notes. We
tried to contact these women and were able to reach
one, who was not aware that she had a chronic infection
with HBV and whose child did not receive any HBV vac-
cinations. The second woman was lost to follow up.
The clinics providing health services to pregnant UM
all cited similar challenges in regards to follow up and
adequate treatment of pregnant women. If women did
not return to obtain their screening results, a referral
could be made to initiate treatment or plan for vaccin-
ation, putting the child (and potentially sexual partners)
at risk of infection. Additionally, the clinics were operated
by many health care staff who mostly work on a volunteer
basis. The clinics provided services often supplied by spe-
cialists in the regular healthcare system, and even though
volunteers were highly qualified, they might not have the
familiarity with all the situations they encountered at the
clinics, compared to someone who routinely performs the
work. It was difficult to maintain consistent training on
standard operating procedures for all volunteers working
at the clinics. At the time of the investigation, the three
clinics were among very few options available to UM to
obtain basic perinatal services.
Bias and limitations
As the population studied consisted of undocumented
individuals, we had to use a convenience sample of all
UM presenting to one of three NGO clinics during the
study period. We had no information on the proportion
of pregnant UM who did present to a clinic, and there-
fore are unable to tell how many additional women
missed screening. We could not tell if the women pre-
senting to a health clinic were representative of the preg-
nant UM in Denmark, and if they were more or less
healthy. It is possible that entire ethnic groups did not
attend a health clinic if there were barriers to seeking
health care that we are unable to quantify.
We collected information from clinics with different
population profiles: clinic A may be more representative
of a general UM population, whilst women attending
clinics B and C were almost exclusively sex workers. Sex
workers were at higher risk of infection with HIV, HBV
and syphilis and could lead to an overestimation of the
illness. We did not however see any HIV infection in
any of the sex worker clinics, and did not observe a
significant difference in HBV prevalence between the sex
worker clinics and the general UM clinic.
We could only collect retrospective data and were lim-
ited to information collected in the clinic records. We
were able to identify reasons for not testing for 30 of 77
women who were eligible for screening but had no test
result recorded. For the remaining 61 % we were unable
to identify if women with no record of testing available
were truly not tested, or if this is a record keeping issue.
It is possible that negative test results are less often re-
corded, which could lead to an overestimation of preva-
lence, or that additional positives have been missed by
failure to test, which could lead to an underestimation of
prevalence. One woman was reported to have tested
positive for HBV elsewhere but no laboratory test result
was available in the clinic records. This woman was
therefore excluded from the prevalence analysis, but had
she been included, the prevalence of HBV in UM would
have been even higher.
Conclusions
Our results show much lower access to pregnancy
screening for UM compared to the Danish population.
Additionally, despite the small sample size, results show
a higher prevalence of HBV infection in pregnant UM
compared to DM after adjustment for region or origin,
emphasising that screening of this population is essential
to protect the unborn child.
Potential perceived risk by UM of utilizing systematic
screening within the Danish health care system may in-
clude the fear of having personal data recorded in an of-
ficial register. These data could be used inappropriately
for the seizure and expulsion of UM, who may therefore
choose not to utilise screening. Given the high propor-
tion of pregnancies in UM women seeking healthcare,
we do believe however, that if a safe and accessible ser-
vice for screening were available, pregnant UM would
choose to use this to ensure good health during their
pregnancy and favourable outcomes for their children.
Providing free and systematic access to pregnancy
screening is in line with international treaties ratified by
the Danish government, agreeing to provide equal and
equitable access to health care for UM, including pre-
and postnatal care and right to health for children of
UM [1]. Additionally, preventative measures have been
shown to be cost effective [20–22]. Currently, the clinics
providing pregnancy care to UM operate on budgets reli-
ant on fund raising and donations. This poses challenges
when aiming to ensure continuous management of
chronic infections such as HIV and HBV. Interruptions in
treatment can have detrimental consequences for patients.
To our knowledge, this study is the first attempt to
quantify access of UM to pregnancy screening in
Denmark and to estimate the prevalence of HIV, HBV
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and syphilis in this population. Based on our results, we
believe that including pregnant UM women in routine
pregnancy screening programs and offering them peri-
natal care will lead to earlier presentation to health care
services and improve screening coverage for preventable
infectious diseases to protect the child from vertical
transmission with HIV, HBV and syphilis. We recommend
giving systematic access to routine pregnancy screening to
all UM, integrated into the regular healthcare system, to
protect newborn babies from infection with preventable
diseases and to address the observed health care inequity.
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